{"transactions":[{"id":758922,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-29T20:22:34.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option vest on the earlier of (i) the one year anniversary of May 27, 2026 or (ii) immediately prior to the next Annual Meeting following May 27, 2026."}],"balance_after":80000,"derivative":{"exercise_price":1.86,"expiration_date":"2036-05-26","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001610717-26-000171","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000161071726000171/form4.xml","form_type":"4"}},{"id":1129436,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-30T22:30:37.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"100% of the shares subject to the option vest on the earlier of (i) the one year anniversary of May 28, 2025 or (ii) immediately prior to the next Annual Meeting following May 28, 2025."}],"balance_after":80000,"derivative":{"exercise_price":0.72,"expiration_date":"2035-05-27","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0000950170-25-079921","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000095017025079921/ownership.xml","form_type":"4"}},{"id":1129435,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-30T22:30:37.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":28571,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On May 28, 2025, the Issuer's stockholders approved an option repricing at an exercise price of $0.72 per share (the \"Repricing\") of the outstanding stock options held by members of the Board, certain employees and other service providers. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to the option shall vest on the earlier of (i) one year anniversary of June 13, 2024 or (ii) immediately prior to the next Annual Meeting following June 13, 2024."}],"balance_after":28571,"derivative":{"exercise_price":0.72,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":28571},"source":{"system":"sec-edgar","filing":"0000950170-25-079921","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000095017025079921/ownership.xml","form_type":"4"}},{"id":1129434,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-30T22:30:37.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":46455,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On May 28, 2025, the Issuer's stockholders approved an option repricing at an exercise price of $0.72 per share (the \"Repricing\") of the outstanding stock options held by members of the Board, certain employees and other service providers. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option vest on each monthly anniversary measured from September 8, 2023 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date."}],"balance_after":46455,"derivative":{"exercise_price":0.72,"expiration_date":"2033-09-14","underlying":"Common Stock","underlying_shares":46455},"source":{"system":"sec-edgar","filing":"0000950170-25-079921","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000095017025079921/ownership.xml","form_type":"4"}},{"id":1129433,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-30T22:30:37.000Z","date":"2025-05-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":28571,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to the option shall vest on the earlier of (i) one year anniversary of June 13, 2024 or (ii) immediately prior to the next Annual Meeting following June 13, 2024."}],"balance_after":0,"derivative":{"exercise_price":1.69,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":28571},"source":{"system":"sec-edgar","filing":"0000950170-25-079921","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000095017025079921/ownership.xml","form_type":"4"}},{"id":1129432,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-30T22:30:37.000Z","date":"2025-05-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":46455,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option vest on each monthly anniversary measured from September 8, 2023 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date."}],"balance_after":0,"derivative":{"exercise_price":1.69,"expiration_date":"2033-09-14","underlying":"Common Stock","underlying_shares":46455},"source":{"system":"sec-edgar","filing":"0000950170-25-079921","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000095017025079921/ownership.xml","form_type":"4"}},{"id":1264098,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-18T21:30:06.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":28571,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the \"Repricing\") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to the option shall vest on the earlier of (i) one year anniversary of June 13, 2024 or (ii) immediately prior to the next Annual Meeting following June 13, 2024."}],"balance_after":28571,"derivative":{"exercise_price":1.69,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":28571},"source":{"system":"sec-edgar","filing":"0000950170-25-022321","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000095017025022321/ownership.xml","form_type":"4"}},{"id":1264097,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-18T21:30:06.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":46455,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the \"Repricing\") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option vest on each monthly anniversary measured from September 8, 2023 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date."}],"balance_after":46455,"derivative":{"exercise_price":1.69,"expiration_date":"2033-09-14","underlying":"Common Stock","underlying_shares":46455},"source":{"system":"sec-edgar","filing":"0000950170-25-022321","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000095017025022321/ownership.xml","form_type":"4"}},{"id":1264096,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-18T21:30:06.000Z","date":"2025-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":28571,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to the option shall vest on the earlier of (i) one year anniversary of June 13, 2024 or (ii) immediately prior to the next Annual Meeting following June 13, 2024."}],"balance_after":0,"derivative":{"exercise_price":9.95,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":28571},"source":{"system":"sec-edgar","filing":"0000950170-25-022321","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000095017025022321/ownership.xml","form_type":"4"}},{"id":1264095,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-18T21:30:06.000Z","date":"2025-02-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":46455,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option vest on each monthly anniversary measured from September 8, 2023 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date."}],"balance_after":0,"derivative":{"exercise_price":17,"expiration_date":"2033-09-14","underlying":"Common Stock","underlying_shares":46455},"source":{"system":"sec-edgar","filing":"0000950170-25-022321","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000095017025022321/ownership.xml","form_type":"4"}},{"id":1479378,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T20:16:21.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":28571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the option shall vest on the earlier of (i) one year anniversary of June 13, 2024 or (ii) immediately prior to the next Annual Meeting following June 13, 2024."}],"balance_after":28571,"derivative":{"exercise_price":9.95,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":28571},"source":{"system":"sec-edgar","filing":"0001610717-24-000337","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000161071724000337/form4.xml","form_type":"4"}},{"id":1479377,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-14T20:16:21.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":20100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of June 13, 2024 or (ii) immediately prior to the next Annual Meeting following June 13, 2024."}],"balance_after":20100,"source":{"system":"sec-edgar","filing":"0001610717-24-000337","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000161071724000337/form4.xml","form_type":"4"}},{"id":1779114,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-18T21:56:31.000Z","date":"2023-09-14","kind":"grant","planned":false,"acquired":true,"shares":46455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option vest on each monthly anniversary measured from September 8, 2023 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date."}],"balance_after":46455,"derivative":{"exercise_price":17,"expiration_date":"2033-09-13","underlying":"Common Stock","underlying_shares":46455},"source":{"system":"sec-edgar","filing":"0001610717-23-000285","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000161071723000285/form4.xml","form_type":"4"}},{"id":88888,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Nqso (Right to Buy)","published_at":"2021-05-04T23:38:00.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":6159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 4/30/2023, 4/30/2024 and 4/30/2025, respectively."}],"balance_after":6159,"derivative":{"exercise_price":239.64,"exercise_date":"2023-04-30","expiration_date":"2031-04-30","underlying":"Common Stock","underlying_shares":6159},"source":{"system":"sec-edgar","filing":"0001127602-21-015364","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221015364/form4.xml","form_type":"4"}},{"id":88887,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2021-05-04T23:38:00.000Z","date":"2021-05-03","kind":"tax_withholding","acquired":false,"shares":220,"price":239.64,"value":52720.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 326 RSUs which will vest on 4/27/2022; 1,133 RSUs which will vest in installments of 558 on 5/3/2022 and 575 on 5/3/2023; 1,269 RSUs which vest in installments of 418 on 5/5/2022, 419 on 5/5/2023 and 432 on 5/5/2024; and 709 RSUs which vest in installments of 233 on 4/30/2023, 234 on 4/30/2024 and 242 on 4/30/2025. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 134 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":44787,"source":{"system":"sec-edgar","filing":"0001127602-21-015364","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221015364/form4.xml","form_type":"4"}},{"id":88886,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2021-05-04T23:38:00.000Z","date":"2021-05-01","kind":"tax_withholding","acquired":false,"shares":139,"price":239.64,"value":33309.96,"ownership":{"direct":true},"balance_after":45007,"source":{"system":"sec-edgar","filing":"0001127602-21-015364","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221015364/form4.xml","form_type":"4"}},{"id":88885,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2021-05-04T23:38:00.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/30/2023, 4/30/2024 and 4/30/2025, respectively."}],"balance_after":45146,"source":{"system":"sec-edgar","filing":"0001127602-21-015364","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221015364/form4.xml","form_type":"4"}},{"id":89161,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2021-04-29T00:14:28.000Z","date":"2021-04-27","kind":"tax_withholding","acquired":false,"shares":128,"price":255.52,"value":32706.56,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 335 RSUs which will vest on 5/1/2021; 326 RSUs which will vest on 4/27/2022; 1,691 RSUs which will vest in two installments of 558 on 5/3/2021 and 5/3/2022 and one installment of 575 on 5/3/2023; and 1,269 RSUs which vest in installments of 418 on 5/5/2022, 419 on 5/5/2023 and 432 on 5/5/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 206 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":44437,"source":{"system":"sec-edgar","filing":"0001127602-21-014605","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221014605/form4.xml","form_type":"4"}},{"id":90724,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2021-03-22T22:33:06.000Z","date":"2021-03-19","kind":"tax_withholding","acquired":false,"shares":991,"price":244.42,"value":242220.22,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 335 RSUs which vest on 5/1/2021; 642 RSUs which vest in installments of 316 on 4/27/2021 and 326 on 4/27/2022; 1,691 RSUs which will vest in two installments of 558 on 5/3/2021 and 5/3/2022 and one installment of 575 on 5/3/2023; and 1,269 RSUs which vest in installments of 418 on 5/5/2022, 419 on 5/5/2023 and 432 on 5/5/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 234 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":44565,"source":{"system":"sec-edgar","filing":"0001127602-21-011714","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221011714/form4.xml","form_type":"4"}},{"id":91655,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2021-03-05T01:33:35.000Z","date":"2021-03-02","kind":"grant","acquired":true,"shares":2648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 335 RSUs which vest on 5/1/2021; 642 RSUs which vest in installments of 316 on 4/27/2021 and 326 on 4/27/2022; 1,691 RSUs which will vest in two installments of 558 on 5/3/2021 and 5/3/2022 and one installment of 575 on 5/3/2023; and 1,269 RSUs which vest in installments of 418 on 5/5/2022, 419 on 5/5/2023 and 432 on 5/5/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 202 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":45504,"source":{"system":"sec-edgar","filing":"0001127602-21-009482","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760221009482/form4.xml","form_type":"4"}},{"id":104956,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Nqso (Right to Buy)","published_at":"2020-05-08T01:03:24.000Z","date":"2020-05-05","kind":"grant","acquired":true,"shares":10628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/5/2022, 5/5/2023 and 5/5/2024, respectively."}],"balance_after":10628,"derivative":{"exercise_price":236.36,"exercise_date":"2022-05-05","expiration_date":"2030-05-05","underlying":"Common Stock","underlying_shares":10628},"source":{"system":"sec-edgar","filing":"0001127602-20-015864","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760220015864/form4.xml","form_type":"4"}},{"id":104955,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2020-05-08T01:03:24.000Z","date":"2020-05-05","kind":"grant","acquired":true,"shares":1269,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 5/5/2022, 5/5/2023 and 5/5/2024, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 335 RSUs which vest on 5/1/2021; 642 RSUs which vest in installments of 316 on 4/27/2021 and 326 on 4/27/2022; 1,691 RSUs which will vest in two installments of 558 on 5/3/2021 and 5/3/2022 and one installment of 575 on 5/3/2023; and 1,269 RSUs which vest in installments of 418 on 5/5/2022, 419 on 5/5/2023 and 432 on 5/5/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 119 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":42773,"source":{"system":"sec-edgar","filing":"0001127602-20-015864","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760220015864/form4.xml","form_type":"4"}},{"id":105062,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2020-05-05T23:55:37.000Z","date":"2020-05-03","kind":"tax_withholding","acquired":false,"shares":136,"price":230.98,"value":31413.28,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 335 RSUs which vest on 5/1/2021; 642 RSUs which vest in installments of 316 on 4/27/2021 and 326 on 4/27/2022; and 1,691 RSUs which will vest in two installments of 558 on 5/3/2021 and 5/3/2022 and one installment of 575 on 5/3/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 119 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":41504,"source":{"system":"sec-edgar","filing":"0001127602-20-015551","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760220015551/form4.xml","form_type":"4"}},{"id":105061,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2020-05-05T23:55:37.000Z","date":"2020-05-01","kind":"tax_withholding","acquired":false,"shares":123,"price":239.22,"value":29424.06,"ownership":{"direct":true},"balance_after":41640,"source":{"system":"sec-edgar","filing":"0001127602-20-015551","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760220015551/form4.xml","form_type":"4"}},{"id":105259,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2020-04-29T23:02:31.000Z","date":"2020-04-27","kind":"tax_withholding","acquired":false,"shares":116,"price":236.28,"value":27408.48,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 348 RSUs which vest in one installment on 5/3/2020; 660 RSUs which vest in installments of 325 on 5/1/2020 and 335 on 5/1/2021; 642 RSUs which vest in installments of 316 on 4/27/2021 and 326 on 4/27/2022; and 1,691 RSUs which will vest in two installments of 558 on 5/3/2021 and 5/3/2022 and one installment of 575 on 5/3/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 188 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":41763,"source":{"system":"sec-edgar","filing":"0001127602-20-014701","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760220014701/form4.xml","form_type":"4"}},{"id":105969,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2020-03-24T22:03:21.000Z","date":"2020-03-20","kind":"tax_withholding","acquired":false,"shares":1591,"price":198.76,"value":316227.16,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 348 RSUs which vest in one installment on 5/3/2020; 660 RSUs which vest in installments of 325 on 5/1/2020 and 335 on 5/1/2021; 957 RSUs which vest in installments of 315 on 4/27/2020, 316 on 4/27/2021 and 326 on 4/27/2022; and 1,691 RSUs which will vest in two installments of 558 on 5/3/2021 and 5/3/2022 and one installment of 575 on 5/3/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 206 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":41879,"source":{"system":"sec-edgar","filing":"0001127602-20-011869","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760220011869/form4.xml","form_type":"4"}},{"id":106398,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2020-03-06T00:52:00.000Z","date":"2020-03-03","kind":"grant","acquired":true,"shares":3711,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 348 RSUs which vest in one installment on 5/3/2020; 660 RSUs which vest in installments of 325 on 5/1/2020 and 335 on 5/1/2021; 957 RSUs which vest in installments of 315 on 4/27/2020, 316 on 4/27/2021 and 326 on 4/27/2022; and 1,691 RSUs which will vest in two installments of 558 on 5/3/2021 and 5/3/2022 and one installment of 575 on 5/3/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 176 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":43411,"source":{"system":"sec-edgar","filing":"0001127602-20-009711","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760220009711/form4.xml","form_type":"4"}},{"id":108142,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2020-02-08T01:25:28.000Z","date":"2020-02-06","kind":"sale","acquired":false,"shares":9264,"price":229.9308,"value":2130078.9312,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is an average price. Full information regarding the number of shares sold at each separate price is available upon request by the SEC staff, the issuer or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 348 RSUs which vest in one installment on 5/3/2020; 660 RSUs which vest in installments of 325 on 5/1/2020 and 335 on 5/1/2021; 957 RSUs which vest in installments of 315 on 4/27/2020, 316 on 4/27/2021 and 326 on 4/27/2022; and 1,691 RSUs which will vest in two installments of 558 on 5/3/2021 and 5/3/2022 and one installment of 575 on 5/3/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 176 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":39700,"source":{"system":"sec-edgar","filing":"0001127602-20-004438","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760220004438/form4.xml","form_type":"4"}},{"id":109837,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Nqso (Right to Buy)","published_at":"2019-12-14T01:31:29.000Z","date":"2019-12-13","kind":"exercise","acquired":true,"shares":2875,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5839,"derivative":{"exercise_price":162.6,"exercise_date":"2019-05-01","expiration_date":"2027-05-01","underlying":"Common Stock","underlying_shares":2875},"source":{"system":"sec-edgar","filing":"0001127602-19-034963","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219034963/form4.xml","form_type":"4"}},{"id":109836,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2019-12-14T01:31:29.000Z","date":"2019-12-13","kind":"tax_withholding","acquired":false,"shares":2425,"price":235.99,"value":572275.75,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Non-market exercise of 2,875 stock options expiring May 1, 2027 wherein 2,425 shares issuable pursuant to the exercise of these options were withheld by the Company to cover the option exercise price and tax withholding, with the remaining shares delivered to the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 348 RSUs which vest in one installment on 5/3/2020; 660 RSUs which vest in installments of 325 on 5/1/2020 and 335 on 5/1/2021; 957 RSUs which vest in installments of 315 on 4/27/2020, 316 on 4/27/2021 and 326 on 4/27/2022; and 1,691 RSUs which will vest in two installments of 558 on 5/3/2021 and 5/3/2022 and one installment of 575 on 5/3/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 176 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":48964,"source":{"system":"sec-edgar","filing":"0001127602-19-034963","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219034963/form4.xml","form_type":"4"}},{"id":109835,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2019-12-14T01:31:29.000Z","date":"2019-12-13","kind":"exercise","acquired":false,"shares":2875,"price":162.6,"value":467475.0,"ownership":{"direct":true},"balance_after":51389,"source":{"system":"sec-edgar","filing":"0001127602-19-034963","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219034963/form4.xml","form_type":"4"}},{"id":110430,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Nqso (Right to Buy)","published_at":"2019-11-21T01:09:28.000Z","date":"2019-11-20","kind":"exercise","acquired":false,"shares":5749,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2962,"derivative":{"exercise_price":156.35,"exercise_date":"2018-05-03","expiration_date":"2026-05-03","underlying":"Common Stock","underlying_shares":5749},"source":{"system":"sec-edgar","filing":"0001127602-19-033442","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219033442/form4.xml","form_type":"4"}},{"id":110429,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2019-11-21T01:09:28.000Z","date":"2019-11-20","kind":"tax_withholding","acquired":false,"shares":4870,"price":224.5,"value":1093315.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Non-market exercise of 5,749 stock options expiring May 3, 2026 wherein 4,870 shares issuable pursuant to the exercise of these options were withheld by the Company to cover the option exercise price and tax withholding, with the remaining shares delivered to the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 348 RSUs which vest in one installment on 5/3/2020; 660 RSUs which vest in installments of 325 on 5/1/2020 and 335 on 5/1/2021; 957 RSUs which vest in installments of 315 on 4/27/2020, 316 on 4/27/2021 and 326 on 4/27/2022; and 1,691 RSUs which will vest in two installments of 558 on 5/3/2021 and 5/3/2022 and one installment of 575 on 5/3/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 153 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":48491,"source":{"system":"sec-edgar","filing":"0001127602-19-033442","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219033442/form4.xml","form_type":"4"}},{"id":110428,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2019-11-21T01:09:28.000Z","date":"2019-11-20","kind":"exercise","acquired":true,"shares":5749,"price":156.35,"value":898856.15,"ownership":{"direct":true},"balance_after":53361,"source":{"system":"sec-edgar","filing":"0001127602-19-033442","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219033442/form4.xml","form_type":"4"}},{"id":116878,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Nqso (Right to Buy)","published_at":"2019-05-07T23:04:16.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":14768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/3/2021, 5/3/2022 and 5/3/2023, respectively."}],"balance_after":14768,"derivative":{"exercise_price":177.31,"exercise_date":"2021-05-03","expiration_date":"2029-05-03","underlying":"Common Stock","underlying_shares":14768},"source":{"system":"sec-edgar","filing":"0001127602-19-017652","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219017652/form4.xml","form_type":"4"}},{"id":116877,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2019-05-07T23:04:16.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":1691,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 5/3/2021, 5/3/2022 and 5/3/2023, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 348 RSUs which vest on 5/3/2020; 660 RSUs which vest in installments of 325 on 5/1/2020 and 335 on 5/1/2021; 957 RSUs which vest in installments of 315 on 4/27/2020, 316 on 4/27/2021 and 326 on 4/27/2022; and 1,691 RSUs which will vest in two installments of 558 on 5/3/2021 and 5/3/2022 and one installment of 575 on 5/3/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 96 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":47555,"source":{"system":"sec-edgar","filing":"0001127602-19-017652","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219017652/form4.xml","form_type":"4"}},{"id":116876,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2019-05-07T23:04:16.000Z","date":"2019-05-03","kind":"tax_withholding","acquired":false,"shares":182,"price":176.5,"value":32123.0,"ownership":{"direct":true},"balance_after":45864,"source":{"system":"sec-edgar","filing":"0001127602-19-017652","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219017652/form4.xml","form_type":"4"}},{"id":117032,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2019-05-03T22:02:20.000Z","date":"2019-05-01","kind":"tax_withholding","acquired":false,"shares":171,"price":179.3232,"value":30664.2672,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 686 RSUs which vest in one installment of 338 on 5/3/2019 and one installment of 348 on 5/3/2020; 660 RSUs which vest in installments of 325 on 5/1/2020 and 335 on 5/1/2021; and 957 RSUs which vest in installments of 315 on 4/27/2020, 316 on 4/27/2021 and 326 on 4/27/2022. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 124 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":46046,"source":{"system":"sec-edgar","filing":"0001127602-19-017355","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219017355/form4.xml","form_type":"4"}},{"id":118125,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2019-03-25T23:39:58.000Z","date":"2019-03-22","kind":"tax_withholding","acquired":false,"shares":1509,"price":191.89,"value":289562.01,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 686 RSUs which vest in one installment of 338 on 5/3/2019 and one installment of 348 on 5/3/2020; 984 RSUs which vest in installments of 324 on 5/1/2019, 325 on 5/1/2020 and 335 on 5/1/2021; and 957 RSUs which vest in installments of 315 on 4/27/2020, 316 on 4/27/2021 and 326 on 4/27/2022. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 142 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":46217,"source":{"system":"sec-edgar","filing":"0001127602-19-013164","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219013164/form4.xml","form_type":"4"}},{"id":118672,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2019-03-09T00:43:11.000Z","date":"2019-03-06","kind":"grant","acquired":true,"shares":3676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 686 RSUs which vest in one installment of 338 on 5/3/2019 and one installment of 348 on 5/3/2020; 984 RSUs which vest in installments of 324 on 5/1/2019, 325 on 5/1/2020 and 335 on 5/1/2021; and 957 RSUs which vest in installments of 315 on 4/27/2020, 316 on 4/27/2021 and 326 on 4/27/2022. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 120 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":47674,"source":{"system":"sec-edgar","filing":"0001127602-19-010658","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219010658/form4.xml","form_type":"4"}},{"id":120685,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2019-02-01T23:22:48.000Z","date":"2019-01-30","kind":"tax_withholding","acquired":false,"shares":162,"price":192.11,"value":31121.82,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 686 RSUs which vest in one installment of 338 on 5/3/2019 and one installment of 348 on 5/3/2020; 984 RSUs which vest in installments of 324 on 5/1/2019, 325 on 5/1/2020 and 335 on 5/1/2021; and 957 RSUs which vest in installments of 315 on 4/27/2020, 316 on 4/27/2021 and 326 on 4/27/2022. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 120 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":43998,"source":{"system":"sec-edgar","filing":"0001127602-19-003512","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760219003512/form4.xml","form_type":"4"}},{"id":122155,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Nqso (Right to Buy)","published_at":"2018-12-04T01:13:29.000Z","date":"2018-11-30","kind":"exercise","acquired":false,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":54.69,"exercise_date":"2013-04-25","expiration_date":"2021-04-25","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001127602-18-035030","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218035030/form4.xml","form_type":"4"}},{"id":122154,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2018-12-04T01:13:29.000Z","date":"2018-11-30","kind":"tax_withholding","acquired":false,"shares":4109,"price":202.37,"value":831538.33,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Non-market exercise of 6,500 stock options expiring April 25, 2021 wherein 4,109 shares issuable pursuant to the exercise of these options were withheld by the Company to cover the option exercise price and tax withholding, with the remaining shares delivered to the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 357 RSUs which vest in one installment on 1/30/2019; 686 RSUs which vest in one installment of 338 on 5/3/2019 and one installment of 348 on 5/3/2020; 984 RSUs which vest in installments of 324 on 5/1/2019, 325 on 5/1/2020 and 335 on 5/1/2021; and 957 RSUs which vest in installments of 315 on 4/27/2020, 316 on 4/27/2021 and 326 on 4/27/2022. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 136 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":41019,"source":{"system":"sec-edgar","filing":"0001127602-18-035030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218035030/form4.xml","form_type":"4"}},{"id":122153,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2018-12-04T01:13:29.000Z","date":"2018-11-30","kind":"exercise","acquired":true,"shares":6500,"price":54.69,"value":355485.0,"ownership":{"direct":true},"balance_after":45128,"source":{"system":"sec-edgar","filing":"0001127602-18-035030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218035030/form4.xml","form_type":"4"}},{"id":128928,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Nqso (Right to Buy)","published_at":"2018-05-15T23:55:30.000Z","date":"2018-05-11","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":54.71,"exercise_date":"2012-08-03","expiration_date":"2020-08-03","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001127602-18-017562","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218017562/form4.xml","form_type":"4"}},{"id":128927,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2018-05-15T23:55:30.000Z","date":"2018-05-11","kind":"tax_withholding","acquired":false,"shares":9860,"price":170.77,"value":1683792.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Non-market exercise of 15,000 stock options expiring August 3, 2020 wherein 9,860 shares issuable pursuant to the exercise of these options were withheld by the Company to cover the option exercise price and tax withholding, with the remaining shares delivered to the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 357 RSUs which vest in one installment on 1/30/2019; 686 RSUs which vest in one installment of 338 on 5/3/2019 and one installment of 348 on 5/3/2020; 984 RSUs which vest in installments of 324 on 5/1/2019, 325 on 5/1/2020 and 335 on 5/1/2021; and 957 RSUs which vest in installments of 315 on 4/27/2020, 316 on 4/27/2021 and 326 on 4/27/2022. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 94 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":41706,"source":{"system":"sec-edgar","filing":"0001127602-18-017562","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218017562/form4.xml","form_type":"4"}},{"id":128926,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2018-05-15T23:55:30.000Z","date":"2018-05-11","kind":"exercise","acquired":true,"shares":15000,"price":54.71,"value":820650.0,"ownership":{"direct":true},"balance_after":51566,"source":{"system":"sec-edgar","filing":"0001127602-18-017562","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218017562/form4.xml","form_type":"4"}},{"id":129152,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2018-05-07T23:11:51.000Z","date":"2018-05-03","kind":"tax_withholding","acquired":false,"shares":178,"price":169.43,"value":30158.54,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 357 RSUs which vest in one installment on 1/30/2019; 686 RSUs which vest in one installment of 338 on 5/3/2019 and one installment of 348 on 5/3/2020; and 984 RSUs which vest in installments of 324 on 5/1/2019, 325 on 5/1/2020 and 335 on 5/1/2021. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 94 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":36566,"source":{"system":"sec-edgar","filing":"0001127602-18-016539","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218016539/form4.xml","form_type":"4"}},{"id":129433,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Nqso (Right to Buy)","published_at":"2018-05-01T23:22:18.000Z","date":"2018-04-27","kind":"grant","acquired":true,"shares":7374,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 4/27/2020, 4/27/2021 and 4/27/2022, respectively."}],"balance_after":7374,"derivative":{"exercise_price":177.46,"exercise_date":"2020-04-27","expiration_date":"2028-04-27","underlying":"Common Stock","underlying_shares":7374},"source":{"system":"sec-edgar","filing":"0001127602-18-015843","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218015843/form4.xml","form_type":"4"}},{"id":129432,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2018-05-01T23:22:18.000Z","date":"2018-04-27","kind":"grant","acquired":true,"shares":957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 4/27/2020, 4/27/2021 and 4/27/2022, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 357 RSUs which vest in one installment on 1/30/2019; 1,023 RSUs with vest in 3 annual installments of 337, 338 and 348 on 5/3/2018, 5/3/2019 and 5/3/2020, respectively; and 984 RSUs which vest in installments of 324 on 5/1/2019, 325 on 5/1/2020 and 335 on 5/1/2021. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 112 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":36744,"source":{"system":"sec-edgar","filing":"0001127602-18-015843","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218015843/form4.xml","form_type":"4"}},{"id":129588,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2018-04-26T23:17:01.000Z","date":"2018-04-25","kind":"tax_withholding","acquired":false,"shares":217,"price":171.94,"value":37310.98,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 357 RSUs which vest in one installment on 1/30/2019; 1,023 RSUs with vest in 3 annual installments of 337, 338 and 348 on 5/3/2018, 5/3/2019 and 5/3/2020, respectively; and 984 RSUs which vest in installments of 324 on 5/1/2019, 325 on 5/1/2020 and 335 on 5/1/2021. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 112 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":35787,"source":{"system":"sec-edgar","filing":"0001127602-18-015366","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218015366/form4.xml","form_type":"4"}},{"id":130434,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2018-03-27T23:48:56.000Z","date":"2018-03-23","kind":"tax_withholding","acquired":false,"shares":1519,"price":176.08,"value":267465.52,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 397 RSUs which vest on 4/25/2018; 357 RSUs which vest in one installment on 1/30/2019; 1,023 RSUs with vest in 3 annual installments of 337, 338 and 348 on 5/3/2018, 5/3/2019 and 5/3/2020, respectively; and 984 RSUs which vest in installments of 324 on 5/1/2019, 325 on 5/1/2020 and 335 on 5/1/2021. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 150 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":36004,"source":{"system":"sec-edgar","filing":"0001127602-18-012861","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218012861/form4.xml","form_type":"4"}},{"id":131004,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2018-03-10T00:34:47.000Z","date":"2018-03-07","kind":"grant","acquired":true,"shares":4031,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 397 RSUs which vest on 4/25/2018; 357 RSUs which vest in one installment on 1/30/2019; 1,023 RSUs with vest in 3 annual installments of 337, 338 and 348 on 5/3/2018, 5/3/2019 and 5/3/2020, respectively; and 984 RSUs which vest in installments of 324 on 5/1/2019, 325 on 5/1/2020 and 335 on 5/1/2021. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 130 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":37474,"source":{"system":"sec-edgar","filing":"0001127602-18-011024","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218011024/form4.xml","form_type":"4"}},{"id":133246,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2018-01-31T01:38:37.000Z","date":"2018-01-30","kind":"tax_withholding","acquired":false,"shares":153,"price":198,"value":30294.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following RSUs granted under the Company's equity plans: 397 RSUs which vest on 4/25/2018; 357 RSUs which vest in one installment on 1/30/2018; 1,023 RSUs with vest in 3 annual installments of 337, 338 and 348 on 5/3/2018, 5/3/2019 and 5/3/2020, respectively; and 984 RSUs which vest in installments of 324 on 5/1/2019, 325 on 5/1/2020 and 335 on 5/1/2021. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 130 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":33443,"source":{"system":"sec-edgar","filing":"0001127602-18-003054","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760218003054/form4.xml","form_type":"4"}},{"id":140977,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Nqso (Right to Buy)","published_at":"2017-05-04T00:58:50.000Z","date":"2017-05-01","kind":"grant","acquired":true,"shares":8714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively."}],"balance_after":8714,"derivative":{"exercise_price":162.6,"exercise_date":"2019-05-01","expiration_date":"2027-05-01","underlying":"Common Stock","underlying_shares":8714},"source":{"system":"sec-edgar","filing":"0001127602-17-016759","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760217016759/form4.xml","form_type":"4"}},{"id":140976,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2017-05-04T00:58:50.000Z","date":"2017-05-01","kind":"grant","acquired":true,"shares":984,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 397 RSUs which vest on 4/25/2018; 704 RSUs which vest in two installments of 347 and 357 on 1/30/2018 and 1/30/2019, respectively; 1,023 RSUs with vest in 3 annual installments of 337, 338 and 348 on 5/3/2018, 5/3/2019 and 5/3/2020, respectively; and 984 RSUs which vest in installments of 324 on 5/1/2019, 325 on 5/1/2020 and 335 on 5/1/2021. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.mmon stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 92 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":33533,"source":{"system":"sec-edgar","filing":"0001127602-17-016759","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760217016759/form4.xml","form_type":"4"}},{"id":141246,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2017-04-27T00:10:16.000Z","date":"2017-04-26","kind":"tax_withholding","acquired":false,"shares":2620,"price":164.7,"value":431514.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 397 RSUs which vest on 4/25/2018; 704 RSUs which vest in two  installments of 347 and 357 on 1/30/2018 and 1/30/2019, respectively; and 1,023 RSUs with vest in 3 annual installments of 337, 338 and 348 on 5/3/2018, 5/3/2019 and 5/3/2020, respectively.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 92 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":32549,"source":{"system":"sec-edgar","filing":"0001127602-17-015593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760217015593/form4.xml","form_type":"4"}},{"id":141245,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2017-04-27T00:10:16.000Z","date":"2017-04-26","kind":"tax_withholding","acquired":false,"shares":163,"price":164.7,"value":26846.1,"ownership":{"direct":true},"balance_after":35169,"source":{"system":"sec-edgar","filing":"0001127602-17-015593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760217015593/form4.xml","form_type":"4"}},{"id":141244,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2017-04-27T00:10:16.000Z","date":"2017-04-25","kind":"tax_withholding","acquired":false,"shares":215,"price":163.14,"value":35075.1,"ownership":{"direct":true},"balance_after":35332,"source":{"system":"sec-edgar","filing":"0001127602-17-015593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760217015593/form4.xml","form_type":"4"}},{"id":141760,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2017-03-28T23:01:59.000Z","date":"2017-03-24","kind":"tax_withholding","acquired":false,"shares":2528,"price":166.04,"value":419749.12,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 286 RSUs which vest on 4/26/2017; 4,613 RSUs which vest on 4/26/2017; 782 RSUs which vest in two installments of 385 and 397 on 4/25/2017 and 4/25/2018, respectively; 704 RSUs which vest in two  installments of 347 and 357 on 1/30/2018 and 1/30/2019, respectively; and 1,023 RSUs with vest in 3 annual installments of 337, 338 and 348 on 5/3/2018, 5/3/2019 and 5/3/2020, respectively.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 546 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":35547,"source":{"system":"sec-edgar","filing":"0001127602-17-013098","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760217013098/form4.xml","form_type":"4"}},{"id":142316,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2017-03-09T22:17:40.000Z","date":"2017-03-07","kind":"grant","acquired":true,"shares":5635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 286 RSUs which vest on 4/26/2017; 4,613 RSUs which vest on 4/26/2017; 782 RSUs which vest in two installments of 385 and 397 on 4/25/2017 and 4/25/2018, respectively; 704 RSUs which vest in two  installments of 347 and 357 on 1/30/2018 and 1/30/2019, respectively; and 1,023 RSUs with vest in 3 annual installments of 337, 338 and 348 on 5/3/2018, 5/3/2019 and 5/3/2020, respectively.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 496 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":37989,"source":{"system":"sec-edgar","filing":"0001127602-17-011104","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760217011104/form4.xml","form_type":"4"}},{"id":144388,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2017-02-01T00:27:36.000Z","date":"2017-01-30","kind":"tax_withholding","acquired":false,"shares":160,"price":157.16,"value":25145.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 286 RSUs which vest on 4/26/2017; 4,613 RSUs which vest on 4/26/2017; 782 RSUs which vest in two installments of 385 and 397 on 4/25/2017 and 4/25/2018, respectively; 704 RSUs which vest in two  installments of 347 and 357 on 1/30/2018 and 1/30/2019, respectively; and 1,023 RSUs with vest in 3 annual installments of 337, 338 and 348 on 5/3/2018, 5/3/2019 and 5/3/2020, respectively.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 496 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":32354,"source":{"system":"sec-edgar","filing":"0001127602-17-003216","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760217003216/form4.xml","form_type":"4"}},{"id":153047,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Nqso (Right to Buy)","published_at":"2016-05-06T00:38:45.000Z","date":"2016-05-03","kind":"grant","acquired":true,"shares":8711,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/3/2018, 5/3/2019 and 5/3/2020, respectively."}],"balance_after":8711,"derivative":{"exercise_price":156.35,"exercise_date":"2018-05-03","expiration_date":"2026-05-03","underlying":"Common Stock","underlying_shares":8711},"source":{"system":"sec-edgar","filing":"0001127602-16-051295","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760216051295/form4.xml","form_type":"4"}},{"id":153046,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2016-05-06T00:38:45.000Z","date":"2016-05-03","kind":"grant","acquired":true,"shares":1023,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 5/3/2018, 5/3/2019 and 5/3/2020, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 286 RSUs which vest on 4/26/2017; 4,613 RSUs which vest on 4/26/2017; 782 RSUs which vest in two installments of 385 and 397 on 4/25/2017 and 4/25/2018, respectively; 1,050 RSUs which vest in three annual installments of 346, 347 and 357 on 1/30/2017, 1/30/2018 and 1/30/2019, respectively; and 1,023 RSUs which vest in three installments of 337, 338 and 348 on 5/3/2018, 5/3/2019 and 5/3/2020, respectively.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 357 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":32359,"source":{"system":"sec-edgar","filing":"0001127602-16-051295","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760216051295/form4.xml","form_type":"4"}},{"id":153449,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2016-04-29T00:48:18.000Z","date":"2016-04-27","kind":"tax_withholding","acquired":false,"shares":289,"price":162.85,"value":47063.65,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 286 RSUs which vest on 4/26/2017; 4,613 RSUs which vest on 4/26/2017; 782 RSUs which vest in two installments of 385 and 397 on 4/25/2017 and 4/25/2018, respectively; and 1,050 RSUs which vest in three annual installments of 346, 347 and 357 on 1/30/2017, 1/30/2018 and 1/30/2019, respectively.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 357 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":31336,"source":{"system":"sec-edgar","filing":"0001127602-16-050230","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760216050230/form4.xml","form_type":"4"}},{"id":153448,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2016-04-29T00:48:18.000Z","date":"2016-04-26","kind":"tax_withholding","acquired":false,"shares":154,"price":163.46,"value":25172.84,"ownership":{"direct":true},"balance_after":31635,"source":{"system":"sec-edgar","filing":"0001127602-16-050230","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760216050230/form4.xml","form_type":"4"}},{"id":153626,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2016-04-26T23:42:00.000Z","date":"2016-04-25","kind":"tax_withholding","acquired":false,"shares":210,"price":163.19,"value":34269.9,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 510 RSUs which vest on 4/27/2016; 563 RSUs which vest in one installment of 277 on 4/26/2016 and one installment of 286 on 4/26/2017; 4,613 RSUs which vest on 4/26/2017; 782 RSUs which vest in two installments of 385 and 397 on 4/25/2017 and 4/25/2018, respectively; and 1,050 RSUs which vest in three annual installments of 346, 347 and 357 on 1/30/2017, 1/30/2018 and 1/30/2019, respectively.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 413 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":31789,"source":{"system":"sec-edgar","filing":"0001127602-16-049947","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760216049947/form4.xml","form_type":"4"}},{"id":154326,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2016-03-29T21:26:24.000Z","date":"2016-03-25","kind":"tax_withholding","acquired":false,"shares":2307,"price":149.24,"value":344296.68,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 510 RSUs which vest on 4/27/2016; 563 RSUs which vest in one installment of 277 on 4/26/2016 and one installment of 286 on 4/26/2017; 4,613 RSUs which vest on 4/26/2017; 1,166 RSUs which vest in annual installments of 384, 385 and 397 on 4/25/2016, 4/25/2017 and 4/25/2018, respectively; and 1,050 RSUs which vest in three annual installments of 346, 347 and 357 on 1/30/2017, 1/30/2018 and 1/30/2019, respectively.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 428 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":31999,"source":{"system":"sec-edgar","filing":"0001127602-16-047740","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760216047740/form4.xml","form_type":"4"}},{"id":155067,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2016-03-04T23:22:17.000Z","date":"2016-03-02","kind":"grant","acquired":true,"shares":5305,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 510 RSUs which vest on 4/27/2016; 563 RSUs which vest in one installment of 277 on 4/26/2016 and one installment of 286 on 4/26/2017; 4,613 RSUs which vest on 4/26/2017; 1,166 RSUs which vest in annual installments of 384, 385 and 397 on 4/25/2016, 4/25/2017 and 4/25/2018, respectively; and 1,050 RSUs which vest in three annual installments of 346, 347 and 357 on 1/30/2017, 1/30/2018 and 1/30/2019, respectively.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 371 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":34212,"source":{"system":"sec-edgar","filing":"0001127602-16-045132","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760216045132/form4.xml","form_type":"4"}},{"id":164467,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2015-04-29T00:10:06.000Z","date":"2015-04-27","kind":"tax_withholding","acquired":false,"shares":274,"price":167.91,"value":46007.34,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include 248 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":28784,"source":{"system":"sec-edgar","filing":"0001127602-15-015482","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760215015482/form4.xml","form_type":"4"}},{"id":164466,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2015-04-29T00:10:06.000Z","date":"2015-04-26","kind":"tax_withholding","acquired":false,"shares":2497,"price":167.91,"value":419271.27,"ownership":{"direct":true},"balance_after":29058,"source":{"system":"sec-edgar","filing":"0001127602-15-015482","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760215015482/form4.xml","form_type":"4"}},{"id":164465,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2015-04-29T00:10:06.000Z","date":"2015-04-26","kind":"tax_withholding","acquired":false,"shares":151,"price":167.91,"value":25354.41,"ownership":{"direct":true},"balance_after":31555,"source":{"system":"sec-edgar","filing":"0001127602-15-015482","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760215015482/form4.xml","form_type":"4"}},{"id":164464,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2015-04-29T00:10:06.000Z","date":"2015-04-25","kind":"tax_withholding","acquired":false,"shares":330,"price":167.91,"value":55410.3,"ownership":{"direct":true},"balance_after":31706,"source":{"system":"sec-edgar","filing":"0001127602-15-015482","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760215015482/form4.xml","form_type":"4"}},{"id":165307,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2015-03-31T22:59:53.000Z","date":"2015-03-27","kind":"tax_withholding","acquired":false,"shares":4402,"price":160.55,"value":706741.1,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 632 RSUs which fully vest on 4/25/2015; 1,005 RSUs which vest in two annual installments of 495 on 4/27/2015 and 510 on 4/27/2016; 840 RSUs which vest in two equal installments of 277 each on 4/26/2015 and 4/26/2016 and one installment of 286 on 4/26/2017; 9,226 RSUs which vest in two equal installments of 4,613 each on 4/26/2015 and 4/26/2017; 1,166 RSUs which vest in annual installments of 384, 385 and 397 on 4/25/2016, 4/25/2017 and 4/25/2018, respectively; and 1,050 RSUs which vest in three annual installments of 346, 347 and 357 on 1/30/2017, 1/30/2018 and 1/30/2019, respectively.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 455 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":32036,"source":{"system":"sec-edgar","filing":"0001127602-15-012985","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760215012985/form4.xml","form_type":"4"}},{"id":165876,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2015-03-07T02:10:01.000Z","date":"2015-03-04","kind":"grant","acquired":true,"shares":9459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 632 RSUs which fully vest on 4/25/2015; 1,005 RSUs which vest in two annual installments of 495 on 4/27/2015 and 510 on 4/27/2016; 840 RSUs which vest in two equal installments of 277 each on 4/26/2015 and 4/26/2016 and one installment of 286 on 4/26/2017; 9,226 RSUs which vest in two equal installments of 4,613 each on 4/26/2015 and 4/26/2017; 1,166 RSUs which vest in annual installments of 384, 385 and 397 on 4/25/2016, 4/25/2017 and 4/25/2018, respectively; and 1,050 RSUs which vest in three annual installments of 346, 347 and 357 on 1/30/2017, 1/30/2018 and 1/30/2019, respectively.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 386 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":36321,"source":{"system":"sec-edgar","filing":"0001127602-15-010548","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760215010548/form4.xml","form_type":"4"}},{"id":167229,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2015-02-04T00:12:12.000Z","date":"2015-01-30","kind":"grant","acquired":true,"shares":1050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 1/30/2017, 1/30/2018 and 1/30/2019, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 632 RSUs which fully vest on 4/25/2015; 1,005 RSUs which vest in two annual installments of 495 on 4/27/2015 and 510 on 4/27/2016; 840 RSUs which vest in two equal installments of 277 each on 4/26/2015 and 4/26/2016 and one installment of 286 on 4/26/2017; 9,226 RSUs which vest in two equal installments of 4,613 each on 4/26/2015 and 4/26/2017; 1,166 RSUs which vest in annual installments of 384, 385 and 397 on 4/25/2016, 4/25/2017 and 4/25/2018, respectively; and 1,050 RSUs which vest in three annual installments of 346, 347 and 357 on 1/30/2017, 1/30/2018 and 1/30/2019, respectively.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 386 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":26862,"source":{"system":"sec-edgar","filing":"0001127602-15-004145","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760215004145/form4.xml","form_type":"4"}},{"id":171290,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2014-08-04T23:26:18.000Z","date":"2014-08-03","kind":"tax_withholding","acquired":false,"shares":1957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 632 RSUs which fully vest on 4/25/2015; 1,005 RSUs which vest in 2 annual installments of 495 on 4/27/2015 and 510 on 4/27/2016; 840 RSUs which vest in 2 equal installments of 277 each on 4/26/2015 and 4/26/2016 and one installment of 286 on 4/26/2017; 9,226 RSUs which vest in 2 equal installments of 4,163 each on 4/26/2015 and 4/26/2017; and 1,166 RSUs which vest in annual installments of 384, 385 and 397 on 4/25/2016, 4/25/2017 and 4/25/2018, respectively.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 285 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":25711,"source":{"system":"sec-edgar","filing":"0001127602-14-024687","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760214024687/form4.xml","form_type":"4"}},{"id":174284,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2014-04-29T21:59:27.000Z","date":"2014-04-27","kind":"tax_withholding","acquired":false,"shares":10,"price":111.41,"value":1114.1,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include the following RSUs granted under the Company's equity plans: 3,750 RSUs which fully vest on 8/3/2014; 632 RSUs which fully vest on 4/25/2015; 1,005 RSUs which vest in 2 annual installments of 495 on 4/27/2015 and 510 on 4/27/2016; 840 RSUs which vest in 2 equal installments of 277 each on 4/26/2015 and 4/26/2016 and one installment of 286 on 4/26/2017; and 9,226 RSUs which vest in 2 equal installments of 4,163 each on 4/26/2015 and 4/26/2017.  Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include 221 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan.  DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount."}],"balance_after":27604,"source":{"system":"sec-edgar","filing":"0001127602-14-015512","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760214015512/form4.xml","form_type":"4"}},{"id":174283,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2014-04-29T21:59:27.000Z","date":"2014-04-27","kind":"tax_withholding","acquired":false,"shares":259,"price":111.41,"value":28855.19,"ownership":{"direct":true},"balance_after":27614,"source":{"system":"sec-edgar","filing":"0001127602-14-015512","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760214015512/form4.xml","form_type":"4"}},{"id":174282,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2014-04-29T21:59:27.000Z","date":"2014-04-25","kind":"grant","acquired":true,"shares":1166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 4/25/2016, 4/25/2017 and 4/25/2018."}],"balance_after":27873,"source":{"system":"sec-edgar","filing":"0001127602-14-015512","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760214015512/form4.xml","form_type":"4"}},{"id":174281,"issuer":{"id":2832,"kind":"organization","name":"AMGEN INC","symbol":"AMGN"},"owners":[{"id":11752,"kind":"person","name":"Piacquad David","position":1,"cik":"0001602343","reported_name":"Piacquad David","relationship":{"officer":true,"officer_title":"SVP, Business Development"}}],"security":"Common Stock","published_at":"2014-04-29T21:59:27.000Z","date":"2014-04-25","kind":"tax_withholding","acquired":false,"shares":320,"price":113.72,"value":36390.4,"ownership":{"direct":true},"balance_after":26707,"source":{"system":"sec-edgar","filing":"0001127602-14-015512","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318154/000112760214015512/form4.xml","form_type":"4"}}]}